[
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Conversely, the brain affects gut microbiota composition and function through alterations in mucus and biofilm production, modulation of gastrointestinal motility, changes in intestinal permeability, and regulation of immune function [22].Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This developmental trajectory is further shaped by the long-term dietary regimen, encompassing dietary fibres, resistant starch, and other saccharides, which contribute to the continuous modulation of the gut microbiome (Fig. 1) [9–14, 313].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Dysbiosis of the gut microbiota and brain behaviour\nA functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A functional and compositional shift in the microbiome that deviates from homeostasis is referred to as gut microbial dysbiosis, with various factors contributing to this, as shown in Fig. 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These studies provide a better understanding that the composition of gut microbiota differs between benign and malignant tumours compared to normal samples (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Mechanistic role of gut microbiota in the regulation of brain cancer\n\n\nBrain cancer subtype\nCancer patients/models\nIntervention/treatment\nModulation of microbiota\nMechanism of action\nReferences\n\n\n\nGlioblastoma\nGL261 syngeneic glioblastoma mice\nHigh glucose drink\n\n↑Rikenellaceae strain, Desulfovibrionaceae strain, Odoribacteraceae strain\n↓FR888536_f strain, Phophyromonadaceae strain, Lactobacillaceae strain, Lachnospiraceae strain\n\n\n↑CD4+ TC cell/FOXP3+ Treg ratio, CD8+ TC cell/FOXP3+ Treg ratio, IFNγ, Isg15 Ifi27l2a, Ifit1, Ifit2, Ifit3\n↓Isg20, Ifitm1, Ifitm2, and Ifitm3\n\n[195]\n\n\nGL261 syngeneic glioblastoma mice\nHigh glucose drink + Desulfovibrio vulgaris\n\n↑Desulfovibrio vulgaris\n\n↑Survival\n[195]\n\n\nGlioma\nU87-MG, U251-MG cell lines\nSerum from Taohong Siwu Decoction fed SPF mice\n\n-\n\n\n↑CSF3, PLAU, UHRF1, FOSL1, IL1B, DUSP6, MCM2, CCND1, WNT7B, MCM5, MCL1, SH2B3, MCM3, HNRNPM, PALM2AKAP2\n↓Proliferation, Colony formation, ATF4, FDFT1, ADCY8, CYP1B1, EREG, FAM114A1, EIF4A2, AKR1B1, C14orf132, COL1A2, CDKN1A, ASPH, DEPP1, AKR1C1, DDIT4\n\n[253]\n\n\nGlioma\nOrthotropic xenograft model\nTemozolomide\n\n↑α-diversity indices of Chao1, Shannon, Simpson, Firmicutes, Verrucomicrobiota\n↓Bacteroidota\n\n-\n[192]\n\n\nLuci-GL261 glioma orthotropic xenograft model\nTemozolomide\n\n↑Alloprevotella, Desulfovibrio, Muribaculum\n↓Akkermansia\n\n↓IL-1β, TNF-α, %Macrophages, %Cytotxic T lymphocytes\n[192]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\n\nBifidobacterium lactis + Lactobacillus plantarum\n\n\n↑Firmicutes/Bacteroidetes ratio, Bifidobacterium lactis, Lactobacillus plantarum, Firmicutes\n↓Bacteriodetes,\n\n\n↑Survival, Neurobehaviour, Occludin, PTEN, threonic acid, conduritol b epoxide 1, ascorbate, 5-alpha-cholestan-3-one 1, maltose, 2’-deoxyadenosine, succinate semialdehyde 1, dehydroascorbic acid 1, 4-hydroxypyridine, L-dopa 1\n↓Tumour volume, Ki67+ cells/section, Survivin, p-PI3K, N-cadherin, L-kynurenine 1, beta-glutamic acid 1, albendazole 1, coprostan-3-one, citraconic acid 3, glucosaminic acid, galactinol, methyl yellow, elaidic acid, D-Arabitol\n\n[272]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nTemozolomide\n\n↑Intestimonas, Anaerotruncus, phylum Verrucomicrobia, phylum Deferribateres, genus Akkermansia, genus Bifidobacterium, genus Coprobacillus, genus Clostridium_XVIII, genus Sporobacter, genus Romboutsia, genus Bilophila, genus Anaerotruncus, genus Vampirovibrio, genus Mucispirillum, genus Oscillibacter\n↓genus Coprobacter, genus Barnesiella\n\n↑Glutathione metabolism, fatty acid biosynthesis, mineral absorption, cofactor- and vitamin- biosynthesis\n[193]\n\n\nGlioma\nC57BL/6 N mice\nABX (Vancomycin + Gentamycin + Sucralose)\n\n↑family Alcaligenaceae, family Burkholderiaceae\n↓family Prevotellaceae, family Rikenellacaea, family Helicobacteraceae\n\n\n↑Tumour volume, CD27+/CD11b– NK cells, ARG1, P2RY12, iNOS mRNA\n↓Total NK cells number, Shannon index, CD27+/CD11b+ NK cells\n\n[216]\n\n\nGlioma\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole\n\n↑Ochrobactrum, Klebsiella, Enterobacteriaceae\n↓Bacteroides, Firmicutes\n\n\n↑Tumour Volume\n↓FOXP3\n\n[194]\n\n\nC57BL/6 mice (GLI261-Luc cells)\nAmpicillin, Vancomycin, Neomycin, Metronidazole + Faecal microbiota transplantation\n\n↑genus Bacteroides, genus S24-7, genus Parabacteroides, phylum Bacteriodetes\n↓phylum Proteobacteria, phylum Cyanobacteria\n\n\n↓Tumour Volume\n↑FOXP3\n\n[194]\n\n\nGlioma\nGlioma patient (IDH-WT) samples\nTemozolomide\n↓phylum Verrucomicrobia, Akkermansiaceae, Akkermansia\n\n-\n[184]\n\n\nMalignant glioma\nRecurrent Malignant Glioma patients (n = 15)\nBevacizumab + Temozolomide\n\n↑phylum Actinobacteria, phylum Firmicutes, genus Fusicatenibacter, genus Roseburia, genus Blautia, genus Ruminococcus, genus Anaerotruncus, genus Clostridium_IV, genus Anaerostipes, genus Erysipelotrichaceae_incertae_sedis, genus Sutterellaceae, genus Parasutterella, genus Erysipelotrichia, genus Erysipelotrichales, genus Erysipelotrichaceae, genus Eggerthella, genus Intestinimonas, genus Coriobacteriaceae, genus Coriobacteriales, genus Dorea, genus Faecalibacterium, genus Ruminococcaceae, genus Escherichia_Shigella, genus Clostridium_XlVa, genus Lachnospiraceae, genus Clostridiales, genus Clostridia\n↓phylum Bacteroidetes, phylum Cyanobacteria, genus Streptophyta, genus Bacteroides, genus Scardovia, genus Veillonella\n\n-\n[207]\n\n\nGlioma\nC57BL/6 mice (GL261 cells)\nB. breve, B. longum, B. lactis, and B. bifidum in sterile saline water (4 × 109 CFU/0.4 ml)\n\n↑phylum Firmicutes, phylum Bacteroidetes, phylum Cyanobacteria, phylum Actinobacteria, genus Bifidobacterium, genus Achromobacter, genus Anaerococcus, genus Bacillus, genus Enterobacter, genus Citrobacter, genus Escherichia/Shigella, genus Enhydrobacter, genus Acinetobacter,\ngenus Wautersiell, \n↓phylum Proteobacteria, phylum Myxococcota, genus Raoultella, genus Hydrogenophilus\n\n\n↑Medial survival, Chao1 index, Shannon index, Simpson index, aerobic respiration I (cytochrome c), fatty acid salvage pathway, 1-amino-propan-2-ol, tyrosine, 4-methylene-2-pyrrolidinecarboxylic acid\n↓Tumour volume, phosphocholine, 1,2,3,4-tetrahydroxybutane levels in serum, p-MEK, p-ERK1/2, Wnt5a, PD-L1, NF-κB\n\n[273]\n\n\nGlioma\nC57BL/6 N mice (GL261 cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n\n↑Tumour volume, CD34+ vessel-like structures, Vasculogenesis, CD31, VEGFα, MMP9, CD68, CD133+CD34+ cells, Gly-derivative, leucine, valine, lactate\n↓IL1β, TNFα, ARG1, CD206, speed of process movement of microglial cells, butyrate, propionate, acetate, hypoxanthine, beta-xylose, trimethylamine, uracil, alpha-glucose, nicotinate, beta-galactose, propionate, bile salts 1, glutamate\n\n[237]\n\n\nC57BL/6 N mice (CT-2 A cells)\nABX (Vancomycin, Gentamicin) and sucralose (0.5%)\n-\n↑Tumour volume, Tumour vasculogenesis\n[237]\n\n\nMalignant gliomas\nC57BL/6 mice (GL261 cells)\nDelta-24-RGDOX\n\n↑Actinobacteria, Verrucomicrobia, Bifidobacterium, Akkermansia\n↓Firmicutes/Bacteroidetes ratio\n\n↓Chao1 index, Shannon index\n[309]\n\n\nC57BL/6 mice (GL261 cells)\nIndoximod\n\n↑Turicibacter\n↓Firmicutes/Bacteroidetes ratio\n\n\n↑Survival\n↓Chao1 index, Shannon index\n\n[309]\n\n\nGlioma\nBALB/C nude mice (U251 cells)\n\nSchizophyllum commune fruiting body polysaccharides\n\n↑number of OTUs,  genus Akkermansia, genus unclassified_Oscillospiraceae, genus Parabacteroides, genus [Eubacterium]_fissicatena_group, unclassified_Lachnospiraceae, Akkermansia muciniphila, Ligilactobacillus murinus, unclassified_Oscillospiraceae, Parabacteroides goldsteinii, Phocaeicola vulgatus\n↓phylum Verrucomicrobiota, phylum Bacteroidetes, genus Lachnospiraceae_NK4A136_group, genus Ligilactobacillus\n\n\n↑E-cadherin, cleaved-Caspase-3, ARH1\n↓Tumour volume, N-cadherin, Bcl-2, p-PI3K, p-Akt\n\n[301]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin\n\n↑phylum Proteobacteria, genus Morganella, genus Parasutterella\n↓OTU counts, ACE index, Shannon index, Chao index, phylum Firmicutes, phylum Bacteroidetes, phylum, Tenericutes, phylum Actinobacteria, phylum Deferribacteres, phylum Candidatus_Saccharibacteria, genus Lactobacillus, genus Prevotella, genus Desulfovibrio\n\n\n↑Tumour volume, IL-10, % of CD206+ TAMs\n↓Survival, IFN-γ, IL-2, TNF-α, % of CD86+ TAMs, CD86+/CD206+ ratio, propionic acid, butyric acid, valeric acid, caproic acid, acetic acid (in serum)\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + Faecal microbiota transplantation (from normal mice)\n-\n\n↑Survival\n↓Tumour volume\n\n[217]\n\n\nGlioma\nC57BL/6J mice (GL261 cells)\nRO water supplemented with Ampicillin, Neomycin, Metronidazole, Vancomycin + SCFAs (propionic acid + butyric acid + valeric acid)\n-\n\n↑Survival, % of TAMs, CD86+/CD206+ ratio, % of CD86+ TAMs, CD86, MHC-II, iNOS/Arg-1 ratio, GLUT1, HIF-1α, HK2, PKM2, LDHA\n↓Tumour volume, CD206+ TAMs, CD206\n\n[217]\n\n\nOptic pathway glioma\nNf1OPG mice (germ free)\n-\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice\nVancomycin\n-\n\n↑RNFL thickness\n↓%Ki67+ cells, %Blbp+ cells, %Olig2+ cells, Ccl4, Ccl5, CD8a, CD8+ cells, Ccl3, TGFβ\n\n[283]\n\n\nNf1OPG mice (germ free)\nFaecal microbiota transplantation (from Nf1OPG mice)\n-\n↑%Ki67+ cells, %Blbp+ cells\n[283]\n\n\nNf1OPG mice\nVancomycin + Bacteroides\n\n-\n\n↑%Ki67+ cells, %Blbp+ cells\n↓RNFL thickness\n\n[283]\n\n\n\nOpen in a new tab\n\n↑-Increased, ↓-Decreased\nAKR1B1: aldo-keto reductase family 1 member B; ARG1: arginase 1; ADCY8: adenylate cyclase 8; AKR1C1: aldo-keto reductase family 1 member C1; ARH: ADP-ribosylarginine hydrolase; ASPH: aspartate beta-hydroxylase; ATF4: activating transcription factor 4; Bcl-2: BCL2 apoptosis regulator; C14orf132: mitogen-activated protein kinase 1 interacting protein 1 like; Ccl: C-C motif chemokine ligand; CCND1: cyclin D1; CDKN1A: cyclin dependent kinase inhibitor 1 A; COL1A2: collagen type I alpha 2 chain; CSF3: colony stimulating factor 3; CYP1B1: cytochrome P450 family 1 subfamily B member 1; DDIT4: DNA damage inducible transcript 4; DEPP1: DEPP autophagy regulator 1; DUSP6: dual specificity phosphatase 6; EIF4A2: eukaryotic translation initiation factor 4A2; EREG: epiregulin; ERK: extracellular related kinase; FAM114A1: family with sequence similarity 114 member A1; FDFT1: farnesyl-diphosphate farnesyltransferase 1; FOSL1: FOS like 1, AP-1 transcription factor subunit; FOXP3: forkhead box P3; HIF-1: hypoxia inducible factor 1; HK2: hexokinase 2; HNRNPM: heterogeneous nuclear ribonucleoprotein M; Ifi: interferon alpha inducible protein; Ifit: interferon-induced protein with tetratricopeptide repeats; IL: interleukin; iNOS: inducible nitric oxide synthase; Isg: interferon-stimulated genes; LDHA: lactate dehydrogenase A; MCM: minichromosome maintenance complex component; MCL1: MCL1 apoptosis regulator; MEK: mitogen-activated protein kinase kinase; MMP: matrix metallopeptidase; NF-κB: nuclear factor kappa B subunit; P2RY12: purinergic receptor P2Y12; PALM2AKAP2: paralemmin 2 and A-kinase anchoring protein 2 fusion; PD-L1: programmed cell death 1 ligand 1; PI3K - phosphatidylinositol-4,5-bisphosphate 3-kinase; PKM2: pyruvate kinase M1/2; PLAU: plasminogen activator, urokinase; PTEN: phosphatase and tensin homolog; SH2B3: SH2B adaptor protein 3; TAMs: tumour associated macrophages; Tc cell: cytotoxic T cell; TGFβ: transforming growth factor beta; TNF: tumor necrosis factor; Treg: regulatory T cell; UHRF1: ubiquitin like with PHD and ring finger domains 1; VEGF: vascular endothelial growth factor; Wnt: wingless-type MMTV integration site family; Wnt5a: Wnt family member 5a; WNT7B: Wnt family member 7B\nFig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The microbe in the gut interacts with the brain cancer cells through various signalling molecules that regulate the tumour progression (Table 4) (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]